AdaptHealth Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22 Mai 2024 - 10:30PM
Business Wire
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the
“Company”), a national leader in providing patient-centered,
healthcare-at-home solutions including home medical equipment,
medical supplies, and related services, announced today that
AdaptHealth granted restricted stock units covering 553,251 shares
of the Company’s common stock at target performance levels (the
“Inducement RSUs”) to Suzanne Foster, AdaptHealth’s newly appointed
Chief Executive Officer. The Inducement RSUs were approved by the
Compensation Committee of AdaptHealth’s board of directors on May
11, 2024 and were granted with an effective date of May 20, 2024
(the “Effective Date”) as an inducement material to Ms. Foster’s
employment with AdaptHealth in accordance with Nasdaq Listing Rule
5635(c)(4).
Inducement RSUs covering 229,740 shares of the Company’s common
stock will vest in three equal annual installments beginning on May
20, 2025, the one-year anniversary of the Effective Date, subject
in each case to Ms. Foster’s continued services with AdaptHealth
through the applicable vesting date. Inducement RSUs covering
93,771 shares of the Company’s common stock will vest in two equal
annual installments beginning on May 20, 2025, subject in each case
to Ms. Foster’s continued services with AdaptHealth through the
applicable vesting date. The remainder of the Inducement RSUs will
vest based on the Company’s Total Shareholder Return (“TSR”)
relative to the TSRs of AdaptHealth’s peer companies over a
three-year performance period beginning on May 20, 2024, subject to
Ms. Foster’s continued services with AdaptHealth through the
completion of the performance period, with Inducement RSUs covering
229,740 shares of the Company’s common stock vesting at target
performance levels (and 459,480 shares of the Company’s common
stock at maximum performance levels).
AdaptHealth is providing this information in accordance with
Nasdaq Listing Rule 5635(c)(4).
About AdaptHealth Corp.
AdaptHealth is a national leader in providing patient-centered,
healthcare-at-home solutions including home medical equipment
(“HME”), medical supplies, and related services. The Company
provides a full suite of medical products and solutions designed to
help patients manage chronic conditions in the home, adapt to
challenges in their activities of daily living, and thrive. Product
and service offerings include (i) sleep therapy equipment,
supplies, and related services (including CPAP and bi PAP services)
to individuals suffering from obstructive sleep apnea, (ii) medical
devices and supplies to patients for the treatment of diabetes
(including continuous glucose monitors and insulin pumps), (iii)
HME to patients discharged from acute care and other facilities,
(iv) oxygen and related chronic therapy services in the home, and
(v) other HME devices and supplies on behalf of chronically ill
patients with wound care, urological, incontinence, ostomy and
nutritional supply needs. The Company is proud to partner with an
extensive and highly diversified network of referral sources,
including acute care hospitals, sleep labs, pulmonologists, skilled
nursing facilities, and clinics. AdaptHealth services beneficiaries
of Medicare, Medicaid, and commercial insurance payors, reaching
approximately 4.1 million patients annually in all 50 states
through its network of approximately 670 locations in 47
states.
Forward Looking
Statements
This press release includes forward-looking statements related
to AdaptHealth, including statements regarding the equity grants.
These forward-looking statements are based upon information that is
currently available to AdaptHealth and its current expectations,
speak only as of the date hereof, and are subject to risks and
uncertainties that could cause actual results to differ materially
from those projected, including general economic and market
factors; and other risks discussed in AdaptHealth’s filings with
the SEC, including the Annual Report on Form 10-K for the fiscal
year ended December 31, 2023 filed by AdaptHealth with the SEC on
February 27, 2024, and other reports that AdaptHealth as filed with
the SEC. Any of these may cause AdaptHealth’s actual results,
performance, or achievements to differ materially and adversely
from those anticipated or implied by AdaptHealth’s forward-looking
statements. AdaptHealth expressly disclaims any obligation, except
as required by law, or undertaking to update or revise any such
forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240522519332/en/
AdaptHealth Corp.
Jason Clemens, CFA Chief Financial Officer
Investor Relations ICR Westwicke IR@adapthealth.com
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
Von Jun 2023 bis Jun 2024